SCHEMBL29923752

SCHEMBL29923752

Cc1cc(Cl)ccc1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.64
MAPK1 P28482 2/20 0.64
MAPT P10636 3/20 0.56
HSD17B10 Q99714 1/20 0.52
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
POLB P06746 2/20 0.50
CYP3A4 P08684 1/20 0.50
VCAM1 P19320 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
HPGD P15428 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
PDE7A Q13946 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359844 1.00 TSHR (0.64) TSHRMAPK1MAPTHSD17B10ALDH1A1
Nitrobenzene SCHEMBL11647957 0.88 ALDH1A1 (0.52) TSHRMAPK1MAPTHSD17B10ALDH1A1
SCHEMBL30976988 0.83 TSHR (0.60) TSHRMAPK1MAPTHSD17B10ALDH1A1
SCHEMBL400340 0.83 TSHR (0.60) TSHRMAPK1MAPTHSD17B10ALDH1A1
SCHEMBL10893772 0.82 TSHR (0.48) TSHRMAPK1MAPTHSD17B10ALDH1A1
SCHEMBL7862606 0.81 PDE7A (0.49) TSHRMAPK1MAPTALDH1A1LMNA
SCHEMBL11859872 0.81 TSHR (0.47) TSHRMAPK1MAPTHSD17B10ALDH1A1
SCHEMBL27782473 0.81 LMNA (0.51) TSHRMAPK1MAPTALDH1A1LMNA
SCHEMBL1524058 0.80 MAPK1 (0.72) TSHRMAPK1ALDH1A1LMNAPOLB
Methyl Alcohol SCHEMBL28263562 0.80 TSHR (0.56) TSHRMAPK1MAPTHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed
CN-112334458-B 3-indazolinone compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-11-08 CN disclosed